Results Snapshot
Figures in Million
Consolidate Annual Results
Feb'26
Feb'25
Feb'24
Feb'23
Feb'22
Feb'21
Feb'20
Net Sales
54,982.52
48,393.49
39,900.99
33,897.60
33,595.99
31,603.67
32,042.45
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
54,982.52
48,393.49
39,900.99
33,897.60
33,595.99
31,603.67
32,042.45
Raw Material Cost
48,618.67
42,787.68
35,520.23
30,924.16
30,223.41
28,608.82
28,794.53
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
102.74
63.85
54.02
50.80
58.27
53.74
59.00
Selling and Distribution Expenses
4,267.31
3,623.73
2,543.74
1,712.72
1,765.10
1,715.48
1,759.02
Other Expenses
-10.27
-6.38
-5.40
-5.08
-5.83
-5.37
-5.90
Total Expenditure (Excl Depreciation)
52,885.98
46,411.41
38,063.97
32,636.87
31,988.51
30,324.29
30,553.55
Operating Profit (PBDIT) excl Other Income
2096.5
1982.1000000000001
1837
1260.6999999999998
1607.5
1279.4
1488.8999999999999
Other Income
392.72
380.89
411.44
468.22
283.08
550.18
153.64
Operating Profit (PBDIT)
3,025.00
2,836.32
2,754.54
2,244.98
2,429.39
2,415.96
2,184.37
Interest
102.74
63.85
54.02
50.80
58.27
53.74
59.00
Exceptional Items
-53.27
-107.47
-253.98
-38.82
-24.19
-82.85
-26.73
Gross Profit (PBDT)
6,363.84
5,605.81
4,380.75
2,973.44
3,372.58
2,994.85
3,247.92
Depreciation
844.23
763.41
783.88
841.59
870.47
837.72
825.90
Profit Before Tax
2,024.76
1,901.59
1,662.67
1,313.76
1,476.46
1,441.65
1,272.74
Tax
710.32
754.47
581.07
540.48
607.08
606.66
470.75
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,275.07
1,133.17
1,039.79
759.60
852.33
834.99
801.99
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,275.07
1,133.17
1,039.79
759.60
852.33
834.99
801.99
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
39.36
13.95
41.81
13.69
17.05
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,314.43
1,147.12
1,081.60
773.29
869.38
834.99
801.99
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
15,684.82
14,097.86
13,240.85
12,049.33
11,383.06
10,484.83
10,170.92
Earnings per share (EPS)
338.74
301.35
276.71
202.2
226.92
221.31
210.37
Diluted Earnings per share
338.74
301.35
276.71
202.2
226.92
221.31
210.37
Operating Profit Margin (Excl OI)
3.25%
3.5%
3.91%
2.76%
3.8%
3.25%
3.76%
Gross Profit Margin
5.22%
5.51%
6.13%
6.36%
6.99%
7.21%
6.55%
PAT Margin
2.32%
2.34%
2.61%
2.24%
2.54%
2.64%
2.5%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Feb 2026 is 13.62% vs 21.28% in Feb 2025
Consolidate Net Profit
YoY Growth in year ended Feb 2026 is 14.58% vs 6.06% in Feb 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Feb 2026 is 7.20% vs 4.79% in Feb 2025
Interest
YoY Growth in year ended Feb 2026 is 60.97% vs 18.15% in Feb 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Feb 2026 has fallen from Feb 2025
Compare Annual Results Of Medical Ikkou Group Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
54,982.52
1,00,174.00
-45,191.48
-45.11%
Other Operating Income
0.00
0.00
0.00
Total Operating income
54,982.52
1,00,174.00
-45,191.48
-45.11%
Raw Material Cost
48,618.67
75,882.00
-27,263.33
-35.93%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
102.74
187.00
-84.26
-45.06%
Selling and Distribution Expenses
4,267.31
22,617.00
-18,349.69
-81.13%
Other Expenses
-10.27
-18.70
8.43
45.08%
Total Expenditure (Excl Depreciation)
52,885.98
98,499.00
-45,613.02
-46.31%
Operating Profit (PBDIT) excl Other Income
2,096.53
1,675.00
421.53
25.17%
Other Income
392.72
165.00
227.72
138.01%
Operating Profit (PBDIT)
3,025.00
3,227.00
-202.00
-6.26%
Interest
102.74
187.00
-84.26
-45.06%
Exceptional Items
-53.27
-423.00
369.73
87.41%
Gross Profit (PBDT)
6,363.84
24,292.00
-17,928.16
-73.80%
Depreciation
844.23
1,387.00
-542.77
-39.13%
Profit Before Tax
2,024.76
1,229.00
795.76
64.75%
Tax
710.32
447.00
263.32
58.91%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,275.07
768.00
507.07
66.02%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,275.07
768.00
507.07
66.02%
Share in Profit of Associates
0
0
0.00
Minority Interest
39.36
13.00
26.36
202.77%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,314.43
781.00
533.43
68.30%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
15,684.82
9,796.00
5,888.82
60.11%
Earnings per share (EPS)
338.74
55.47
283.27
510.67%
Diluted Earnings per share
338.74
55.47
283.27
510.67%
Operating Profit Margin (Excl OI)
3.25%
1.67%
0.00
1.58%
Gross Profit Margin
5.22%
2.61%
0.00
2.61%
PAT Margin
2.32%
0.77%
0.00
1.55%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 5,498.25 Million
in Feb 2026Figures in Million
YoY Growth in year ended Feb 2026 is 13.62% vs 21.28% in Feb 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 131.44 Million
in Feb 2026Figures in Million
YoY Growth in year ended Feb 2026 is 14.58% vs 6.06% in Feb 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 263.23 Million
in Feb 2026Figures in Million
YoY Growth in year ended Feb 2026 is 7.20% vs 4.79% in Feb 2025
Annual - Interest
Interest 10.27 Million
in Feb 2026Figures in Million
YoY Growth in year ended Feb 2026 is 60.97% vs 18.15% in Feb 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.25%
in Feb 2026Figures in %
YoY Growth in year ended Feb 2026 has fallen from Feb 2025






